主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
作者:张宇格1韩红亚2马涵英3刘晓丽2罗鸿池3张涵博4刘叠溪4
英文作者:Zhang Yuge1,Han Hongya2,Ma Hanying3,Liu Xiaoli2,Luo Hongchi3,Zhang Hanbo4,Liu Diexi4
单位:1首都医科大学第六临床医学院,北京100029;2首都医科大学附属北京安贞医院老年心血管病中心,北京100029;3首都医科大学附属北京安贞医院全科医疗科,北京100029;4首都医科大学,北京100069
英文单位:1The Sixth Clinical Medical School Capital Medical University Beijing 100029 China; 2Geriatric Cardiovascular Center Beijing Anzhen Hospital Capital Medical University Beijing 100029 China; 3Department of General Medicine Beijing Anzhen Hospital Capital Medical University Beijing 100029 China; 4Capital Medical University Beijing 100069 China
英文关键词:Coronaryatheroscleroticheartdisease;Anxiety;Interventiontherapy
冠心病(冠状动脉粥样硬化性心脏病)与焦虑关系密切,焦虑情绪可以影响冠心病的发展和预后,严重威胁人类身心健康,及时评估冠心病患者心理状态并采取针对性干预措施至关重要。本文就冠心病合并焦虑的影响因素,以及认知行为疗法、生物反馈疗法、中医治疗等干预疗法的最新研究进展进行综述,以期加深临床医师对冠心病合并焦虑的认识,为临床诊治提供参考。
Coronary atherosclerotic heart disease is closely related to anxiety. Anxiety can affect the development and prognosis of coronary atherosclerotic heart disease, which seriously threatens human physical and mental health. It is very important to timely assess the psychological status of patients with coronary atherosclerotic heart disease and take targeted intervention measures. This article reviews the influencing factors of anxiety associated with coronary atherosclerotic heart disease, as well as the latest research progress of cognitive behavioral therapy, biofeedback therapy, traditional Chinese medicine therapy and other intervention therapies of coronary atherosclerotic heart disease complicated with anxiety, in order to deepen clinicians′ understanding of anxiety associated with coronary atherosclerotic heart disease, and provide reference for clinical diagnosis and treatment.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。